Rui Su Selected Research

6-methyladenine

1/2022	FTO in cancer: functions, molecular mechanisms, and therapeutic implications.
1/2022	METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis.
1/2021	Saikosaponin D exhibits anti-leukemic activity by targeting FTO/m6A signaling.
1/2021	YTHDF1 Promotes Gastric Carcinogenesis by Controlling Translation of FZD7.
1/2021	R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis.
1/2020	miR-550-1 functions as a tumor suppressor in acute myeloid leukemia via the hippo signaling pathway.
1/2020	Epitranscriptomics in liver disease: Basic concepts and therapeutic potential.
1/2020	RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia.
11/2018	R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling.
5/2018	RNA N6-methyladenosine modification in cancers: current status and perspectives.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rui Su Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 04/2015
17	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2022 - 11/2015
9	Leukemia 01/2022 - 10/2015
6	Carcinogenesis 01/2022 - 01/2018
5	Infections 01/2021 - 12/2015
4	Inflammation (Inflammations) 01/2022 - 01/2014
4	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2019
4	Stomach Neoplasms (Stomach Cancer) 01/2021 - 04/2015
4	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2015
4	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 11/2017
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2018
3	Rheumatoid Arthritis 01/2022 - 01/2020
3	Alzheimer Disease (Alzheimer's Disease) 09/2021 - 08/2010
3	Neuroblastoma 09/2021 - 12/2019
3	Glioma (Gliomas) 12/2020 - 11/2017
3	Obesity 08/2018 - 01/2014
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2021
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 01/2021
2	T-Cell Leukemia (Leukemia, T Cell) 01/2022 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2021
2	Liver Failure 01/2022 - 02/2017
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2021 - 01/2020
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 09/2021 - 07/2021
2	Cognitive Dysfunction 07/2021 - 10/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2021
2	Liver Diseases (Liver Disease) 12/2020 - 01/2020
2	Brain Neoplasms (Brain Tumor) 01/2020 - 01/2018
2	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2018
2	Body Weight (Weight, Body) 11/2019 - 01/2014
1	Critical Illness (Critically Ill) 04/2022
1	Rectal Neoplasms (Rectal Cancer) 04/2022
1	Anastomotic Leak 04/2022
1	Thalassemia 03/2022
1	Experimental Arthritis 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Hyperbilirubinemia 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Circulating Neoplastic Cells 01/2022
1	Dysbiosis 01/2022

Drug/Important Bio-Agent (IBA)

14	6-methyladenineIBA 01/2022 - 01/2017
11	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2016
10	N-methyladenosineIBA 01/2022 - 01/2017
9	Pharmaceutical PreparationsIBA 01/2022 - 04/2015
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2015
6	Biological ProductsIBA 01/2022 - 11/2017
5	MicroRNAs (MicroRNA)IBA 01/2021 - 04/2015
4	MethyltransferasesIBA 06/2022 - 01/2018
4	Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA 01/2022 - 01/2018
4	CateninsIBA 01/2021 - 04/2015
4	Messenger RNA (mRNA)IBA 12/2020 - 01/2018
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2020
3	Amyloid (Amyloid Fibrils)IBA 09/2021 - 12/2019
3	VaccinesIBA 01/2021 - 01/2017
3	Long Noncoding RNAIBA 01/2020 - 01/2019
2	LigandsIBA 01/2022 - 09/2021
2	Therapeutic UsesIBA 01/2022 - 01/2021
2	Interleukin-2 (IL2)IBA 01/2022 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2014
2	BilirubinIBA 01/2022 - 10/2019
2	AntioxidantsIBA 09/2021 - 01/2020
2	Neuroprotective AgentsIBA 09/2021 - 10/2019
2	AutoantibodiesIBA 01/2021 - 01/2020
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021 - 06/2020
2	Antiviral Agents (Antivirals)IBA 01/2021 - 11/2020
2	CytokinesIBA 01/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
2	Carrier Proteins (Binding Protein)IBA 12/2020 - 01/2020
2	Nerve Growth Factor (NGF)IBA 02/2020 - 12/2019
2	CholesterolIBA 10/2019 - 01/2017
2	Fluorouracil (Carac)FDA LinkGeneric 04/2016 - 05/2015
1	Lysine (L-Lysine)FDA Link 06/2022
1	Hemoglobins (Hemoglobin)IBA 03/2022
1	ginsenoside M1IBA 01/2022
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Arginine (L-Arginine)FDA Link 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	APTIBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	PeroxidasesIBA 01/2022
1	Glycyrrhetinic Acid (Po 12)IBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2022
1	Ferrosoferric Oxide (Magnetite)FDA Link 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	BAY-293IBA 12/2021
1	CationsIBA 12/2021
1	Carnitine (L-Carnitine)FDA LinkGeneric 12/2021
1	Imatinib Mesylate (Gleevec)FDA Link 12/2021

Therapy/Procedure

14	Therapeutics 01/2022 - 05/2015
7	Drug Therapy (Chemotherapy) 12/2020 - 04/2015
3	Immunotherapy 01/2022 - 01/2021
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2021 - 01/2017
1	Critical Care (Surgical Intensive Care) 04/2022
1	Colostomy 04/2022
1	Perinatal Care 03/2022
1	Wearable Electronic Devices 01/2022